Aderis Pharmaceuticals

About:

Aderis Pharmaceuticals focused on discovery, development and commercialization of products for the diagnosis.

Website: http://www.aderis.com

Top Investors: Temasek Holdings, Paladin Capital Group, MDS Capital, Neomed Management, Sanderling Ventures

Description:

Aderis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovery, development and commercialization of products for the diagnosis and treatment of cardio-renal diseases. Discovery Therapeutics' product pipeline includes adenosine agonists and antagonists for the diagnosis and treatment of cardiovascular disease and leukotriene synthesis inhibitors for the treatment of chronic renal disease. In addition the company has license agreements with strategic partners involving novel late stage products for the treatment of Parkinson's disease and diagnosis of coronary artery disease.